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Available online 31 January 2017The enzymatic method was used for the direct resolution of racemic atenolol. The catalytic activities of
commercially available lipases from Candida rugosa (MY and OF) immobilized onto new-synthesized chi-
tosan magnetic nanoparticles [Fe3O4-CS-Et(NH2)2, Fe3O4-CS-Et(NH2)3] in the kinetic resolution of racemic
atenolol were compared. The best results were obtained by using Candida rugosa lipase OF immobilized
onto Fe3O4-CS-Et(NH2)3. Additionally, the enzyme reusability was investigated. It was established that
even after 5 reaction cycles, both lipases from Candida rugosa maintained their high catalytic activities
and operational stabilities. This approach is extremely important from an economical point of view,
because it allows for a direct cost reduction of the biotransformation.
 2017 Elsevier Ltd. All rights reserved.1. Introduction enzyme is more sensitive to reaction media as well as temperature.b-Blockers are drugs, which play an important role in the treat-
ment of many human diseases. Atenolol is an amino-alcohol used
for the treatment of hypertension, arrhythmia problem and angina
pectoris.1,2 Since b-blockers possess an asymmetric carbon atom in
their structure, they have two enantiomeric forms. Although, it has
been proven by many studies that only the (S)-enantiomers of the
mentioned drugs have the therapeutic effects, b-blockers are still
administrated to patients as racemates. Replacing racemic drugs
with enantiomerically pure compounds might develop lesser side
effects. For this reason, there are many strategies or chemical syn-
theses that can be used to obtain enantiomerically pure products,
including the (R)- and (S)-enantiomers of the b-blockers.3–8
The use of enzymes in organic biotransformations has become
an interesting area for scientists. Hydrolases are some of the most
frequently used enzymes, because of their broad substrate spec-
trum and considerable stability. Lipases classified as hydrolyses
are ubiquitous enzymes, which catalyse enantioselective biotrans-
formations, e.g. esterifications, transesterification and hydrolysis to
give enantiomerically pure compounds.9–12 Additionally, lipases do
not require any cofactors, and maintain their operational stability
and catalytic activity both in aqueous and/or organic media. These
enzymes are commercially available in free or immobilized forms.
However, the use of native enzymes is usually associated with sep-
aration issues from reaction mixtures. Additionally, the freeThus, the application of native enzymes in industry is limited. Nev-
ertheless, in order to make enzyme handling in biotechnological
process more convenient, various methods have been employed,
including immobilization. One of the greatest advantage of this
technique is the possibility of reducing the total cost of the bio-
transformation with easy removal and transfer of the immobilized
enzyme from one reactionmixture to another.13,14 Furthermore the
bonded enzymes are usually characterised by an increased catalytic
activity. The immobilization techniques of different enzymes onto
various supports have been reported in numerous studies.15–17
Magnetic nanoparticles are widely used for the physical and
chemical immobilization of various biomolecules, including
lipases. Magnetic nanoparticles contain a superparamagnetic core.
Therefore, their application as enzyme carriers allows for easy sep-
aration of bonded biocatalysts from reaction mixtures, by attract-
ing then with an external magnetic field. This approach allows
for the enzyme to be used in another catalytic system and thus
lower the total cost of biotechnological process. Nevertheless, pure
magnetite (Fe2O3) has a poor colloidal stability and thus requires
stabilization and surface modification. Chitosan is a non-toxic nat-
ural polymer, which is capable for shell covering of magnetic
nanoparticles.18,19 Additionally, the chitosan magnetic nanoparti-
cles could be modified, allowing for covalent bonding of various
enzymes, which seems to be more effective, due to the stabiliza-
tion of enzyme conformation. Furthermore, the simplicity of their
synthesis and the modification of the commonly large surfaces,
have meant that chitosan magnetic nanoparticles have gained a
great attention in material chemistry as promising materials for
many applications.20,21
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two lipases from Candida rugosa (OF and MY) was investigated.
The applied biocatalysts were immobilized onto two types of not
commercially available magnetic nanoparticles, which were syn-
thesized de novo. Furthermore, the reusability of the immobilized
enzyme was tested, and the high catalytic activity of the enzyme
after five reaction cycles was confirmed.
2. Materials and methods
2.1. Chemicals
1,4-Diaminobutane, 2-propanol, acetic acid, acetonitrile,
chitosan (lowmolecularweight), diethylamine, EDC [N-(3-dimethy-
laminopropyl)-N0-ethylcarbodiimide hydrochloride], epichlorohy-
drin, ethanol, ethylenediamine, glutaraldehyde, glycine, iron(II)
chloride tetrahydrate, iron(III) chloride hexahydrate, isopropenyl
acetate, (R)-atenolol, (RS)-atenolol, sodium hydroxide, sodium peri-
odate, sulfo-NHS (N-hydroxy-sulfosuccinimide sodium salt),
toluene were purchased from Sigma–Aldrich Co. (Stainhaim,
Germany).
Lipases from Candida rugosa (MY and OF) were a gift fromMeito
Sangyo Co., Ltd (Japan). The water used herein was prepared with
the use of a Milli-Q Water Purification System (Millipore, Bedford,
MA, USA).
2.2. Instrumentation
The FT-IR Spectrometer model Spectrum Two was purchased
from Perkin Elmer, the Inkubator 1000 and Unimax 1010 were pur-
chased from Heidolph; the Refrigerated CentriVap Concentrator
was purchased from Labconco; the Shimadzu UPLC-MS/MS system
equipped with solvent delivery two pumps LC-30AD combined
with gradient systems, degasser model DGU-20A5, an autosampler
model SIL-30AC, a column oven model CTO-20AC, UV detector
model SPD-M20A and triple quadrupole mass spectrometer detec-
tor model LCMS-8030. Chiral column Lux Cellulose-2 (LC-2) cellu-
lose tris(3-chloro-4-methylphenylcarbamate) and Guard Cartridge
System model KJO-4282 were purchased from Phenomenex Co.
2.3. Chromatographic conditions
The chromatographic process was carried out at 30 C. (RS)-Ate-
nolol and its acetylated derivatives were baseline separated using a
chiral column: Lux Cellulose-2 (4.6 mm  250 mm  3 lm). The
composition of the mobile phase consisted of acetonitrile/2-propa-
nol/diethylamine in a volumetric ratio of 98/2/0.1. The detection
was made with the use of triple quadrupole mass spectrometer
operating with a multiple reaction monitoring mode. The transi-
tions of the multiple reaction monitoring mode for atenolol were
267.20 > 256.05; 267.20 > 190.05; 267.20 > 116.10, whereas for
atenolol acetate were 309.2 > 158.10; 309.20 > 145.15;
309.20 > 116.10. The enantiomeric purity and enantioselectivity
of enantioselective acetylation were determined by using the equa-
tions basing on peak areas from chromatogram obtained from chro-
matographic separation of (RS)-atenolol and its acetylated forms.
2.4. Synthesis of magnetic chitosan nanoparticles coated with a
modified chitosan with two and three long-distanced free
amino groups: Fe3O4-CS-Et-(NH2)2 and Fe3O4-CS-Et-(NH2)32.4.1. Magnetic nanoparticles coated with modified chitosan
with two long-distanced free amino groups (Fe3O4 CS-Et-(NH2)2)
Chitosan (0.2 g) was mixed and mechanically stirred with a 1%
acetic acid solution (20 mL) at room temperature for 20 min. Next,both iron (II) chloride tetrahydrate (0.74 g, 3.75 mmol) and iron(III)
chloride hexahydrate (2.02 g, 7.5 mmol) were added to the previ-
ously obtained mixture and the resulting solution was chemically
precipitated at room temperature by adding dropwise 7 mL of
30% solution of NaOH. A solution of epichlorohydrin (0.2 mL,
2.5 mmol) was then added and the resulting mixture was stirred
at 50 for 2 h. After cooling to the room temperature, sodium peri-
odate solution (0.16 g in 2.5 mL of water) was added and the mix-
ture was stirred for 30 min. Next, 20 mL of aqueous solution of
ethylenediamine (2.4 g, 40 mmol) were added and the mixture
was stirred at room temperature for 2 h. The resulting magnetic
was material were recovered from the suspension by applying a
magnet, washed five times with deionized water and dried under
vacuum at 50 C for 24 h.
2.4.2. Magnetic nanoparticles coated with modified chitosan
with three long-distanced free amino groups (Fe3O4 CS-Et
(NH2)3)
Chitosan (0.2 g) was added into 1% acetic acid solution (20 mL)
and mechanically stirred at room temperature for 20 min. Next,
iron(II) chloride tetrahydrate (0.74 g, 3.75 mmol) as well as iron
(III) chloride hexahydrate (2.02 g, 7.5 mmol) were added (1:2
molar ratio) and the resulting solution was chemically precipitated
at room temperature by adding dropwise a 30% solution of NaOH
(7 mL). To the black mixture that formed was added epichlorohy-
drin (0.2 mL, 2.5 mmol) and the mixture was stirred at 50 for
2 h. After cooling to room temperature, a solution of sodium peri-
odate (0.16 g in 2.5 mL of water) was added and the mixture was
stirred for 30 min. The black precipitate was separated by filtration
and washed with deionized water five times. Next, 10 mL of bicar-
bonate buffer pH – 10 and 10 mL of 5% glutaraldehyde solution
were added and the mixture was mechanically stirred at room
temperature for 1 h, after which 20 mL of an aqueous solution of
ethylenediamine (2.4 g, 40 mmol) were added and the mixture
was stirred at room temperature for 2 h. The resulting magnetic
material was recovered from the suspension by applying a magnet,
washed five times with deionized water and dried under vacuum
at 50 C for 24 h (Fig. 1).
2.5. The immobilization assay of lipases from Candida rugosa
onto the synthesized magnetic nanoparticles
The enantioselective biocatalysts were covalently bonded to the
surface of chitosan magnetic nanoparticles. The resulting amine
bond was formatted between the primary amine group of the mag-
netic nanoparticles and the carboxyl group of the lipase (Fig. 2).
The immobilization procedure was performed according to the
previously reported methodology, with a few modifications.12,18,22
In brief, lipases from Candida rugosa OF and MY (36.5 mg) were
suspended separately in 1.0 mL of 50 mM phosphate buffer (pH
6.4). Next, 2 mg of EDC were dissolved in 50 lL of phosphate buffer
and added to each tube with the suspended lipase. The resulted
solutions were incubated at 21 C and shaken for 1 h. Next,
2.4 mg of sulfo-NHS in 50 lL of phosphate buffer (50 mM,
pH = 6.4) were added to the mixture containing the lipase and
EDC. The solutions were incubated at 21 C for 1 h and shaken.
Next, 50 mg of magnetic nanoparticles (Fe3O4-CS-Et-(NH2)2 and
Fe3O4-CS-Et-(NH2)3) were placed into separate 2 mL centrifuge
tubes with 50 mM of phosphate buffer (pH 6.4) and sonicated for
10 min. All prepared solutions with lipase–EDC–sulfo-NHS com-
plexes were then transferred into separate centrifuge tubes, along
with the previously rinsed chitosan magnetic nanoparticles. The
obtained mixtures were incubated at 21 C for 2 h and shaken at
600 rpm in the thermomixer. Finally, the lipase-immobilized mag-
netic nanoparticles were washed three times with 50 mM of phos-
phate buffer (pH 6.4) and were dried overnight at 30 C. The
Figure 1. Chromatogram of racemic atenolol and its esters: (R)-enantiomer of atenolol acetate (tR = 7,675), (S)-enantiomer of atenolol acetate (tR = 8,474), (S)-atenolol
(tR = 17,378), (R)-atenolol (tR = 19,813). Chromatographic conditions: Lux Cellulose-2 (4.6  250 mm  2 lm) column, mobile phase: acetonitrile/2-propanol/diethylamine
(98/2/0.1 v/v/v), F = 1 mL/min, t = 30 C.
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in the enantioselective acetylation of racemic atenolol.
2.6. Kinetic resolution of (RS)-atenolol
The kinetic resolution of (RS)-atenolol was carried out in 10 mL
of reaction medium. The reaction mixture consisted of toluene,
racemic atenolol (3.0 mg, 0.01 mM), and isopropenyl acetate
(2 lL, 0.018 mM) as the acetyl donor (Fig. 3). The enantioselective
biotransformation was started by the direct addition of the lipase
immobilized on magnetic supports. The reaction mixture was incu-
bated at 35 C along with shaking (250 RPM). The enantioselective
acetylation was monitored with the use of chiral stationary phases
and a UPLC system coupled with triple quadrupole mass spectrom-
eter. The samples were withdrawn at previously established time
points and after evaporating and redissolving in pure acetonitrile,
were injected on the chiral column of UPLC-MS/MS system.3. Results and discussion
3.1. Characterization of the magnetic nanoparticles: Fe3O4-CS-
Et-(NH2)2 and Fe3O4-CS-Et-(NH2)3, native and immobilized
lipase from Candida rugosa
The synthesised magnetic chitosan nanoparticles with free
amine groups were employed for the immobilization of lipase.
The coupling reaction was performed between the amino groups
of the magnetic support and the carboxyl groups of the biocata-
lysts. The structure of the native lipases from Candida rugosa (MY
and OF), the prepared nanoparticles, and the immobilized biocata-
lysts onto nanoparticles were characterized with the Attenuated
Total Reflectance Fourier Transform Infrared (ATR-FTIR) – Spec-
trum TwoTM (Fig. 4). Spectra were recorded in the range of 4000
to 400 cm1. The NAH and C@N characteristics vibration peaks atabout 1540 cm1 and 1640 were observed for both types of mag-
netic nanoparticles (Fe3O4-CS-Et-(NH2)2 and Fe3O4-CS-Et-NH2)3.
The peaks at 766 cm1, 860 cm1 and at 1410 cm1 were observed
to increase with NAH stretching and NAH wagging vibrations in
primary amine groups, however these peaks were not present in
the nanoparticles coated with pure chitosan.19 The signal at
571 cm1 was assigned to the FeAO group of the magnetite. In
the spectrum of the native lipases, the characteristic bands from
the carboxylic groups at 1649, 1540 cm1 and 1646, 1543 cm1
for Candida rugosa lipase OF and MY, respectively, were observed.
After lipase immobilization onto the magnetic nanomaterial, the
spectrum showed two peaks at 1639, 1563 cm1 (Candida rugosa
lipase MY) and 1632, 1651 cm1 (Candida rugosa lipase OF), which
corresponded to the amide bond formation which directly proves
the covalent bonding, which was also reported by numerous
studies.23,20,21
3.2. Enantioselective acetylation of (RS)-atenolol with the use of
immobilized lipases from Candida rugosa onto magnetic
nanoparticles
The enantioselective acetylation of racemic atenolol was per-
formed with the use of lipase from Candida rugosa OF and MY cova-
lently bonded to the chitosan magnetic nanoparticles. The
prepared magnetic nanomaterials differed from each other in
terms of the number of free amine groups on their surface. This
resulted in various amount of immobilized lipases. Nevertheless,
two commercially available lipases attached to two types of mag-
netic nanomaterials showed acceptable parameters of performed
biotransformation (Tables 1 and 2). In all cases, the conversion
value increased with an increase in time. However, among all of
the tested reaction systems, the best result was obtained with
the use of Candida rugosa lipase immobilized onto Fe3O4-CS-Et
(NH2)3. After 240 h of incubation, the (S)-atenolol acetate was


































































































Figure 2. Immobilization of lipases from Candida rugosa using EDC and sulfo-NHS onto the surface of chitosan magnetic nanoparticles.

























Figure 3. Enantioselective acetylation of racemic atenolol with the use of lipase as biocatalyst.
Figure 4. FTIR spectra of the native lipases from Candida rugosa (MY and OF), chitosan magnetic nanoparticles (Fe3O4-CS-Et(NH2)2 and Fe3O4-CS-Et(NH2)3), and immobilized
lipases onto the magnetic nanoparticles.
378 A. Sikora et al. / Tetrahedron: Asymmetry 28 (2017) 374–380product and substrate, which were 93.22% and 70.21%, respec-
tively. The conversion value was c = 42.96%, whereas the enantios-
electivity was 59.96%. The same enzyme immobilized onto Fe3O4-
CS-Et(NH2)2, after 240 h of incubation of the reaction mixture,
allowed for us to obtain the product with eep = 91.78%. However,
in this case, the E value was 38.30, and the conversion was
c = 35.22%. The application of Candida rugosa lipase MY resulted
in the products being obtained with lower enantiomeric excesses
for the two types of magnetic nanomaterials compared to the
results obtained with the use of Candida rugosa lipase OF. The
use of lipase from Candida rugosa MY immobilized onto
Fe3O4-CS-Et(NH2)3 allowed us to obtain the (S)-atenolol acetatewith eep = 91.61%, with c = 37.32% and E = 39.47, after 240 h of
incubating the reaction mixture. The application of lipase from
Candida rugosa MY and the Fe3O4-CS-Et(NH2)2 resulted in obtain-
ing worse parameters describing the kinetic of resolution racemic
atenolol, similar to when lipase OF immobilized onto two types
of magnetic nanoparticles was used.
3.3. Reusability of immobilized lipases from Candida rugosa in
enantioselective acetylation of (RS)-atenolol
The main advantage of using immobilized biocatalysts is the
possibility of reusing the enzyme in another catalytic system.
Table 1
Enzymatic parameters including enantioselectivity (E), enantiomeric excesses of both substrate (ees) and product (eep) and conversion (c) of the enantioselective acetylation of (R,
S)-atenolol with the use of lipase from Candida rugosa OF
Reaction time [h] E ees % eep % c %
Lipase from Candida rugosa OF immobilized onto Fe3O4-CS-Et(NH2)3 24 34.19 16.99 93.32 15.40
48 34.87 25.35 92.92 21.43
72 34.52 31.53 92.42 25.44
96 37.08 39.48 92.36 29.95
120 38.20 43.35 92.29 31.96
144 39.41 48.03 92.15 34.26
168 41.81 55.27 92.00 37.53
192 46.52 61.35 92.26 39.94
216 56.64 67.53 93.09 42.04
240 59.96 70.21 93.22 42.96
Lipase from Candida rugosa OF immobilized onto Fe3O4-CS-Et(NH2)2 24 27.68 15.23 91.95 14.21
48 27.75 18.01 91.76 16.40
72 28.23 21.85 91.60 19.26
96 29.39 25.50 91.64 21.77
120 33.37 33.50 92.02 26.69
144 34.79 38.74 91.94 29.65
168 31.54 40.64 90.98 30.88
192 31.34 43.50 90.67 32.42
216 37.26 47.30 91.78 34.01
240 38.30 49.89 91.78 35.22
Table 2
Enzymatic parameters including enantioselectivity (E), enantiomeric excesses of both substrate (ees) and product (eep) and conversion (c) of enantioselective acetylation of (R,S)-
atenolol with the use of lipase from Candida rugosa MY
Reaction time [h] E ees % eep % c %
Lipase from Candida rugosa OF immobilized onto Fe3O4-CS-Et(NH2)3 24 19.78 10.20 89.41 10.24
48 19.99 14.74 89.07 14.20
72 19.71 16.64 88.73 15.79
96 20.52 21.46 88.67 19.47
120 22.79 25.47 89.35 22.18
144 23.88 33.48 89.03 27.33
168 25.34 40.89 88.87 31.51
192 32.05 46.94 90.55 34.14
216 33.93 52.10 90.56 36.52
240 39.46 54.56 91.61 37.33
Lipase from Candida rugosa MY immobilized onto Fe3O4-CS-Et(NH2)2 24 17.89 13.18 88.04 13.02
48 17.93 15.79 87.78 15.24
72 18.66 16.54 88.14 15.80
96 19.13 18.03 88.26 16.96
120 18.02 18.25 87.56 17.25
144 18.07 20.92 87.29 19.33
168 21.79 27.30 88.70 23.53
192 22.85 33.10 88.61 27.19
216 25.54 37.49 89.31 29.57
240 30.17 47.88 89.89 34.75
93 92 92 90 91 90 89 87 89 
91 
87 86 
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Figure 5. Reusability of the immobilized lipases from Candida ruogosa in enantioselective acetylation of (RS)-atenolol.
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380 A. Sikora et al. / Tetrahedron: Asymmetry 28 (2017) 374–380The influence of the reusability of immobilized lipases on the
kinetic resolution of racemic atenolol was investigated. For this
purpose, the bonded lipases from Candida rugosa OF and MY were
reused after the specified washing procedure. The complexes of the
magnetic nanoparticles and the biocatalysts after the reaction
cycle were recovered from the reaction mixture by external mag-
netic fields and washed with pure toluene. The immobilized lipases
were then dried overnight and placed into new reaction mixtures
to perform the next catalytic cycle. After 5 reaction cycles, the
enantiomeric excesses of products of all tested reaction mixtures
were higher than 90% of the initial value (Fig. 5). The highest value
of enantiomeric excess was obtained with the use of the lipase
from Candida rugosa OF immobilized onto Fe3O4-CS-Et(NH2)2. Nev-
ertheless, the differences of catalytic activity of lipases coupled
with the two types of magnetic nanoparticles after 5 reaction
cycles were not significant. Additionally, it should be stressed that
5 reaction cycles were 1200 h of operational stability of used
enzymes. Thus, the obtained results demonstrated that immobi-
lization procedure and the new-synthesised chitosan magnetic
nanoparticles allowed us to enhance the stability and catalytic
activity of the exploited lipases.
4. Conclusions
Herein the enantioselective acetylation of racemic atenolol
has been catalysed by lipases from Candida rugosa. Two types
of new magnetic nanoparticles were used as carriers for the
biocatalysts. However, the immobilized enzymes exhibited var-
ious kinetic properties, which resulted in different enantioselec-
tivities. Among all of the tested catalytic systems, the best
result was obtained when using lipase from Candida rugosa
OF immobilized onto Fe3O4-CS-Et(NH2)3 (E = 59.96, c = 42.96%,
eep = 93.22%). Additionally, the enzyme reusability was investi-
gated. Even after 5 reaction cycles, both lipases from Candida
rugosa maintained high catalytic activities and operational sta-
bilities. This approach is extremely important from an econom-
ical point of view, since it allows for a direct cost reduction of
the biotransformation.Acknowledgments
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